ID27850A - Penggunaan peningkat penerimaan glukosa untuk mengurangi cedera pasca-iskemia jantung - Google Patents

Penggunaan peningkat penerimaan glukosa untuk mengurangi cedera pasca-iskemia jantung

Info

Publication number
ID27850A
ID27850A IDW20010151A ID20010151A ID27850A ID 27850 A ID27850 A ID 27850A ID W20010151 A IDW20010151 A ID W20010151A ID 20010151 A ID20010151 A ID 20010151A ID 27850 A ID27850 A ID 27850A
Authority
ID
Indonesia
Prior art keywords
iskemia
injury
glucose
reduce heart
increasing reception
Prior art date
Application number
IDW20010151A
Other languages
English (en)
Indonesian (id)
Inventor
A M A Bril
Robin E Buckingham
Nassirah Khandoudi
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9815872.8A external-priority patent/GB9815872D0/en
Priority claimed from GBGB9815871.0A external-priority patent/GB9815871D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID27850A publication Critical patent/ID27850A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IDW20010151A 1998-07-21 1999-07-21 Penggunaan peningkat penerimaan glukosa untuk mengurangi cedera pasca-iskemia jantung ID27850A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9815872.8A GB9815872D0 (en) 1998-07-21 1998-07-21 Novel method
GBGB9815871.0A GB9815871D0 (en) 1998-07-21 1998-07-21 Novel compound

Publications (1)

Publication Number Publication Date
ID27850A true ID27850A (id) 2001-04-26

Family

ID=26314086

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010151A ID27850A (id) 1998-07-21 1999-07-21 Penggunaan peningkat penerimaan glukosa untuk mengurangi cedera pasca-iskemia jantung

Country Status (35)

Country Link
EP (2) EP1098638B1 (no)
JP (1) JP2002521325A (no)
KR (1) KR20010079550A (no)
CN (1) CN1167416C (no)
AP (1) AP1416A (no)
AR (1) AR020614A1 (no)
AT (1) ATE318588T1 (no)
AU (1) AU5053599A (no)
BG (1) BG105251A (no)
BR (1) BR9912144A (no)
CA (1) CA2338216A1 (no)
CO (1) CO5060465A1 (no)
CY (1) CY1106078T1 (no)
CZ (1) CZ2001250A3 (no)
DE (1) DE69930125T2 (no)
DK (1) DK1098638T3 (no)
DZ (1) DZ2854A1 (no)
EA (1) EA004772B1 (no)
ES (1) ES2259839T3 (no)
GC (1) GC0000173A (no)
HU (1) HUP0103870A3 (no)
ID (1) ID27850A (no)
IL (1) IL140741A0 (no)
MA (1) MA26662A1 (no)
NO (1) NO20010293L (no)
NZ (1) NZ509175A (no)
OA (1) OA11583A (no)
PE (1) PE20000881A1 (no)
PL (1) PL345663A1 (no)
PT (1) PT1098638E (no)
SI (1) SI1098638T1 (no)
SK (1) SK1022001A3 (no)
TR (1) TR200100208T2 (no)
TW (2) TW200307532A (no)
WO (1) WO2000004889A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417212B1 (en) 1999-08-27 2002-07-09 Eli Lilly & Company Modulators of peroxisome proliferator activated receptors
CN1592620A (zh) * 2000-06-16 2005-03-09 史密斯克莱·比奇曼公司 与心脏胰岛素抵抗相关的疾病的治疗和预防方法
EP1435894A4 (en) 2001-07-23 2005-07-06 Galileo Pharmaceuticals Inc CYTOPROTECTIVE COMPOUNDS, METHODS AND PHARMACEUTICAL AND COSMETIC FORMULATIONS

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
JPH05202042A (ja) * 1992-01-24 1993-08-10 Sankyo Co Ltd 糖尿病性合併症治療剤
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9611947D0 (en) * 1996-06-07 1996-08-07 Glaxo Group Ltd Medicaments
US6277819B1 (en) * 1996-08-30 2001-08-21 Eli Lilly And Company Use of GLP-1 or analogs in treatment of myocardial infarction
KR20000036035A (ko) * 1996-09-12 2000-06-26 가와무라 요시부미 트로글리타존을 함유하는 글루타티온 환원효소 활성증강제
WO1999025346A1 (en) * 1997-11-19 1999-05-27 Takeda Chemical Industries, Ltd. Novel apoptosis inhibitors
AU2781899A (en) * 1998-02-24 1999-09-15 Trustees Of The University Of Pennsylvania, The Use of a cardiac purinoceptor to effect cellular glucose uptake
AU4005299A (en) * 1998-05-19 1999-12-06 Regents Of The University Of California, The Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis
US5968960A (en) * 1999-01-14 1999-10-19 The Regents Of The University Of California Use of thiazolidinediones to ameliorate the adverse consequences of myocardial ischemia on myocardial function and metabolism

Also Published As

Publication number Publication date
KR20010079550A (ko) 2001-08-22
EP1098638B1 (en) 2006-03-01
DE69930125T2 (de) 2006-10-05
CO5060465A1 (es) 2001-07-30
TW200307532A (en) 2003-12-16
CA2338216A1 (en) 2000-02-03
DE69930125D1 (de) 2006-04-27
HUP0103870A3 (en) 2003-06-30
NO20010293D0 (no) 2001-01-18
PL345663A1 (en) 2002-01-02
EP1523980A2 (en) 2005-04-20
EP1098638A1 (en) 2001-05-16
EA004772B1 (ru) 2004-08-26
PE20000881A1 (es) 2000-10-07
OA11583A (en) 2004-07-01
BG105251A (en) 2001-10-31
EA200100164A1 (ru) 2001-08-27
JP2002521325A (ja) 2002-07-16
BR9912144A (pt) 2001-04-03
ATE318588T1 (de) 2006-03-15
DK1098638T3 (da) 2006-06-19
CZ2001250A3 (cs) 2002-03-13
CN1167416C (zh) 2004-09-22
HUP0103870A2 (hu) 2002-05-29
NZ509175A (en) 2003-10-31
DZ2854A1 (fr) 2003-12-01
PT1098638E (pt) 2006-07-31
NO20010293L (no) 2001-03-07
AP1416A (en) 2005-06-13
EP1523980A3 (en) 2009-03-18
AU5053599A (en) 2000-02-14
SI1098638T1 (sl) 2006-06-30
GC0000173A (en) 2006-03-29
WO2000004889A1 (en) 2000-02-03
IL140741A0 (en) 2002-02-10
MA26662A1 (fr) 2004-12-20
TWI239836B (en) 2005-09-21
TR200100208T2 (tr) 2001-05-21
SK1022001A3 (en) 2001-08-06
AP2001002033A0 (en) 2001-03-31
AR020614A1 (es) 2002-05-22
CY1106078T1 (el) 2011-06-08
CN1310619A (zh) 2001-08-29
ES2259839T3 (es) 2006-10-16

Similar Documents

Publication Publication Date Title
ID28111A (id) Metoda untuk meningkatkan kesehatan kulit
DE60017103D1 (de) Bestimmung der orientierung von elektrokardiogramm-signalen
DE60031836D1 (de) Hautpflegezubereitung die interzelluläre kommunikation vermittelt
ID28947A (id) Metode untuk meringankan inkontinensia uriner wanita
DE69829554D1 (de) Ovalgefortme herzkanüle
DK1051193T3 (da) Vandfrit topisk hudpræparat omfattende ketoconazol
GB9914355D0 (en) Improvements relating to blood sampling devices
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
DE69931855D1 (de) Hautpräparat
EE200200203A (et) Südame arütmia ravis kasutatavad uued oksabispidiinühendid
ID27867A (id) Benda-benda penyerap dapat dibuang yang melekat pada tubuh mempunyai suatu potongan tambahan yang sesuai dengan anatomi tubuh
DE10084458T1 (de) Absorptionsfähige Gewebe zur Verbesserung der Hautschutzschicht
GB2352403B (en) Improvements relating to lancets
EP1242071A4 (en) USE OF PARTHENOLIDE TO INHIBIT CANCER
ID25765A (id) Komposisi pembersih kulit
ID27850A (id) Penggunaan peningkat penerimaan glukosa untuk mengurangi cedera pasca-iskemia jantung
EG22438A (en) Disposable pul-on garment having improved fitness to body
AU6941598A (en) Disposable garment having improved fitness to body during use
ITMI991895A0 (it) Depigmentanti cutanei
ID26986A (id) Penggunaan peningkat penerimaan glukosa untuk mengurangi apoptosis
FIU20000451U0 (fi) Reaktorin sydän
TW402904U (en) Improved structure of disposable dishes
TW431175U (en) Improved structure of disposable earpick
PT1192156E (pt) Novos compostos de bispidina uteis no tratamento de arritmias cardiacas
SE9904322D0 (sv) Hjärtmassageapparat